gliclazide lupin mr gliclazide 60 mg modified release tablet blister pack
lupin australia pty limited - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: povidone; calcium hydrogen phosphate dihydrate; hypromellose; magnesium stearate - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
ardix gliclazide 60 mg mr gliclazide 60 mg tablet blister pack
servier laboratories (aust) pty ltd - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: magnesium stearate; lactose monohydrate; colloidal anhydrous silica; maltodextrin; hypromellose - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg-120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
gliclazide tablet 80 mg (blister)
alphapharm pty ltd - gliclazide, quantity: 80 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; povidone; sodium starch glycollate type a; purified talc; magnesium stearate
pharmacor gliclazide mr gliclazide 60 mg modified release tablet bottle pack
pharmacor pty ltd - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: hypromellose; lactose monohydrate; sodium acetate; mannitol; magnesium stearate; silicon dioxide - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
pharmacor gliclazide mr gliclazide 60 mg modified release tablet blister pack
pharmacor pty ltd - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: mannitol; magnesium stearate; sodium acetate; silicon dioxide; hypromellose; lactose monohydrate - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
pharmacor gliclazide mr gliclazide 30 mg modified release tablet bottle pack
pharmacor pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: hypromellose; magnesium stearate; silicon dioxide; sodium acetate; mannitol; lactose monohydrate - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
apo-gliclazide mr 30mg tablets, bottle
arrotex pharmaceuticals pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: stearic acid; hypromellose; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, gliclazide mr 30 mg tablets, taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
apo-gliclazide mr 30mg tablets, blister pack
arrotex pharmaceuticals pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: hypromellose; stearic acid; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, gliclazide mr 30 mg tablets, taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
apo-gliclazide gliclazide 80mg tablet blister pack
arrotex pharmaceuticals pty ltd - gliclazide, quantity: 80 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica - indicated for the treatment of diabetes mellitus of the maturity onset type, which cannot be controlled by diet alone.
gliclazide-str gliclazide 80 mg tablet blister pack
gm pharma international pty ltd - gliclazide, quantity: 80 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate type a; purified talc; magnesium stearate; povidone; lactose monohydrate; microcrystalline cellulose; purified water - indications: diabetes mellitus of the maturity onset type, which cannot be controlled by diet alone.